XENETIC BIOSCIENCES, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
XENETIC BIOSCIENCES, INC. (XBIO) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$9.26 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-14
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$3.83K.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$5.43K.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$2.18K, a 233.17% decline year-over-year.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $0.00.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$16.79K, a 370.03% decline from fiscal 2015.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $6.22K.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$52.18K.
- XENETIC BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$144.63K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|---|
| 2017-06-30 | -$3.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$9.26K 10-Q · filed 2017-08-14 | -$11.44K derived: sum of 3 quarters · filed 2017-08-14 | -$11.44K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2017-03-31 | -$5.43K 10-Q · filed 2017-05-15 | -$7.61K derived: sum of 2 quarters · filed 2017-05-15 | -$7.61K derived: sum of 3 quarters · filed 2017-05-15 | -$7.61K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-12-31 | -$2.18K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$2.18K derived: sum of 2 quarters · filed 2017-03-31 | -$2.18K derived: sum of 3 quarters · filed 2017-08-14 | -$16.79K 10-K · filed 2017-03-31 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-08-14 | -$14.61K 10-Q · filed 2016-11-14 | -$12.98K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$14.61K 10-Q · filed 2017-08-14 | -$12.98K derived: sum of 3 quarters · filed 2017-08-14 | -$12.98K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | -$14.61K 10-Q · filed 2017-05-15 | -$12.98K derived: sum of 2 quarters · filed 2017-05-15 | -$12.98K derived: sum of 3 quarters · filed 2017-05-15 | -$14.64K derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $1.64K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $1.64K derived: sum of 2 quarters · filed 2017-03-31 | -$26.00 derived: sum of 3 quarters · filed 2017-03-31 | $6.22K 10-K · filed 2017-03-31 | |||
| 2015-09-30 | -$1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$1.66K derived: sum of 2 quarters · filed 2016-11-14 | $4.58K 10-Q · filed 2016-11-14 | -$7.08K derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | -$1.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $4.58K 10-Q · filed 2016-08-15 | -$7.08K derived: sum of 3 quarters · filed 2016-08-15 | -$13.50K derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | $6.25K 10-Q · filed 2016-05-16 | -$5.42K derived: sum of 2 quarters · filed 2016-05-16 | -$11.84K derived: sum of 3 quarters · filed 2016-05-16 | -$34.45K derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | -$11.66K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$18.09K derived: sum of 2 quarters · filed 2016-03-30 | -$40.69K derived: sum of 3 quarters · filed 2016-03-30 | -$52.18K 10-K · filed 2016-03-30 | |||
| 2014-09-30 | -$6.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | -$29.03K derived: sum of 2 quarters · filed 2015-11-16 | -$40.52K 10-Q · filed 2015-11-16 | -$470.52K 10-Q · filed 2014-11-14 | -$170.35K derived: sum of 4 quarters · filed 2015-11-16 | ||
| 2014-06-30 | -$22.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$34.10K 10-Q · filed 2015-08-19 | -$464.10K 10-Q · filed 2014-08-14 | -$163.93K derived: sum of 3 quarters · filed 2015-08-19 | -$168.90K derived: sum of 4 quarters · filed 2015-08-19 | ||
| 2014-03-31 | -$11.49K 10-Q · filed 2015-05-20 | -$441.49K 10-Q · filed 2014-05-20 | -$141.32K derived: sum of 2 quarters · filed 2015-05-20 | -$146.29K derived: sum of 3 quarters · filed 2015-05-20 | -$152.03K derived: sum of 4 quarters · filed 2015-05-20 | ||
| 2013-12-31 | -$129.83K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | -$134.81K derived: sum of 2 quarters · filed 2015-04-15 | -$140.54K derived: sum of 3 quarters · filed 2015-04-15 | -$144.63K 10-K · filed 2015-04-15 | |||
| 2013-09-30 | -$4.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$10.71K derived: sum of 2 quarters · filed 2014-11-14 | -$14.80K 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | -$5.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$9.83K 10-Q · filed 2014-08-14 | |||||
| 2013-03-31 | -$4.09K 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |